Subclinical Primary Aldosteronism Is Characterized by Maladaptive Natriuretic Peptide and Adrenal Hormonal Physiology
The Journal of Clinical Endocrinology & Metabolism · 2025
DOI: 10.1210/clinem/dgaf129 ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift The Journal of Clinical Endocrinology & Metabolism, 2025. Verfasst von Stéfanie Parisien-La Salle und 8 weiteren Autor:innen. Beteiligte Einrichtung: Center for Adrenal Disorders, Division of Endocrinology, Diabetes, and Hypertension, Brigham and Women's Hospital and Harvard Medical School, Boston,…. Hauptthemen laut MEDLINE: Hyperaldosteronism, Aldosterone, Natriuretic Peptide, Brain, Angiotensin II. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 57 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIDDK NIH HHS, NHLBI NIH HHS, American Heart Association Career Development Award.
Abstract (Originalsprache)
Context
A continuum of non-suppressible aldosterone production has been demonstrated in normotensive individuals, termed subclinical primary aldosteronism (PA), and is consistently associated with increased risk for developing hypertension and cardiovascular disease. The hormonal mechanisms accounting for subclinical PA are not well understood.
Methods
To quantify the magnitude of subclinical PA, prospectively recruited normotensive participants (n = 75) had their maximally suppressed plasma aldosterone assessed after maintaining supine posture following an oral sodium loading protocol. To investigate the endocrine mechanisms involved with this continuum, multiple maneuvers were conducted to evaluate: (i) natriuretic peptide physiology (N-terminal pro B-type natriuretic peptide [NT-proBNP] suppression and stimulation using dietary sodium modulation); (ii) angiotensin II (AngII)-dependent aldosterone production (via dietary sodium restriction and via infusion of exogenous AngII); (iii) AngII-independent aldosterone production (via saline suppression test [SST]); and (iv) ACTH-mediated aldosterone production (via dexamethasone suppression test and ACTH-stimulation test).
Results
Greater magnitude of subclinical PA was associated with lower basal NT-proBNP (P-trend < .01) and blunted stimulation of NT-proBNP following sodium loading (P-trend = .023). The magnitude of subclinical PA was also associated with greater AngII-dependent (P-trend < .001) and AngII-independent (P-trend < .001) aldosterone production and paralleled the severity of ACTH-mediated aldosterone production (P-trends < .001). Following SST, 24.2% of participants had a post-saline aldosterone greater than 10 ng/dL and 72.7% had a post-saline aldosterone greater than 6 ng/dL, confirming that the continuum of subclinical PA included overt PA pathophysiology within these normotensive participants.
Conclusion
These findings demonstrate that the pathophysiologic continuum of subclinical PA in normotensive people is characterized by natriuretic peptide insufficiency and heightened aldosterone responses to both AngII and ACTH. These early maladaptive hormonal changes provide mechanistic explanations for the role of subclinical PA in the pathogenesis of hypertension.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Center for Adrenal Disorders, Division of Endocrinology, Diabetes, and Hypertension, Brigham and Women's Hospital and Harvard Medical School, Boston, MA 02115, USA.
- Division of Cardiovascular Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA 02115, USA.
- Department of Internal Medicine, UT Southwestern Medical Center, Dallas, TX 75390, USA.
ORCID-Profile: Anand Vaidya
Förderung
- NIDDK NIH HHS
- NHLBI NIH HHS
- American Heart Association Career Development Award
- National Institutes of Health/National Heart, Lung, and Blood Institute
- NIH HHS
- National Institutes of Health
Zitieren
APA
Parisien-La Salle, S., Brown, J. M., Mahrokhian, S., Hanna, I., Honzel, B., Tsai, L. C., Newman, A. J., Wang, T. J., & Vaidya, A. (2025). Subclinical Primary Aldosteronism Is Characterized by Maladaptive Natriuretic Peptide and Adrenal Hormonal Physiology. The Journal of Clinical Endocrinology & Metabolism. https://doi.org/10.1210/clinem/dgaf129
Vancouver
Parisien-La Salle S, Brown JM, Mahrokhian S, Hanna I, Honzel B, Tsai LC, et al. Subclinical Primary Aldosteronism Is Characterized by Maladaptive Natriuretic Peptide and Adrenal Hormonal Physiology. The Journal of Clinical Endocrinology & Metabolism. 2025. doi:10.1210/clinem/dgaf129
BibTeX
@article{ParisienLaSalle2025,
author = {Parisien-La Salle, Stéfanie and Brown, Jenifer M and Mahrokhian, Sanan and Hanna, Isabelle and Honzel, Brooke and Tsai, Laura C and Newman, Andrew J and Wang, Thomas J and Vaidya, Anand},
title = {Subclinical Primary Aldosteronism Is Characterized by Maladaptive Natriuretic Peptide and Adrenal Hormonal Physiology},
journal = {The Journal of Clinical Endocrinology & Metabolism},
year = {2025},
doi = {10.1210/clinem/dgaf129}
}
EUVIMED